In murine schistosomiasis, granuloma T cells express VPAC2 mRNA, whereas there is none in splenocytes. This suggests that T cell VPAC2 mRNA is inducible. To address this issue, splenocytes from schistosome-infected mice were incubated with anti-CD3 to induce VPAC2 mRNA, which only appeared when cell cultures also contained anti-IL-4 mAb. Granuloma cells expressed VPAC2 mRNA. This natural expression decreased substantially when cells were cultured 3 days in vitro. 
In murine schistosomiasis mansoni, parasites living in the portal vein produce ova that lodge in the liver and intestines of the host. These ova incite focal Th2-type granulomatous inflammation. Various cellcell interactions and cytokines regulate this complex inflammatory response.
Vasoactive intestinal peptide (VIP), a member of the secretin family of neuropeptides, is made by leukocytes within the granulomas of murine schistosomiasis (1) . Although the function of VIP in schistosomiasis is poorly understood, various studies suggest that it affects some aspects of immune responses such as lymphocyte proliferation (2) and trafficking (3, 4) , cytokine production (5, 6), antibody synthesis (7, 8) , natural killer cell activity (9) , and more. In murine schistosomiasis, VIP can inhibit lymphocyte proliferation, suppress IL-2 production, and stimulate IL-5 secretion in vitro (10, 11) .
VIP acts through VIP-specific receptors on cell surfaces. There are two distinct VIP receptors called VPAC1 and VPAC2 (12) . It is unknown whether they have unique functions. Schistosome granulomas are composed of ϳ50% eosinophils, 30% macrophages, 10% T cells, and 5% ␤ cells. Although the VPAC1 receptors are distributed among at least several granuloma cell subtypes, VPAC2 expression appears limited to granuloma T cells (13) . The resting splenic T cells of mice infected with S. mansoni make only VPAC1 mRNA as evidence by a sensitive RT-PCR assay. Here we show that VPAC2 mRNA is subject to induction and regulation in the splenic and granuloma CD4ϩ T lymphocytes. Moreover, VPAC2 mRNA is expressed preferentially in Th1 opposed to Th2 cells, and IL-4 is critically important for restraining VPAC2 production in Th2 cells. These results suggest that VPAC2 may have a role in development and functional differentiation of CD4ϩ T cell subsets.
MATERIALS AND METHODS

Mice and infection
Female CBA/JCR (National Cancer Institute, Bethesda, Md.), C57BL/6J IL-4 knockout, and C57BL/6J littermate control mice (The Jackson Laboratory, Bar Harbor, Maine) were used throughout this study. Mice were infected (s.c.) with 35 cercariae of the Puerto Rican strain of the parasite S. mansoni (14) . At 8 wk of infection, mice were killed to obtain splenocytes and liver granuloma cells.
Isolation and dispersal of splenocytes and granuloma cells
Spleens were dispersed by gently teasing the spleen tissue through a 100 m nylon cell strainer (Becton Dickinson, Rutherford, N.J.) using a rubber policeman and RPMI 1640 medium (Life Technologies, Grand Island, N.Y.). Splenocytes were spun down and resuspended in 5 ml of sterile distilled water for a few seconds to lyse RBC by hypotonic shock. Then, the spleen cells were washed twice in RPMI and resuspended in RPMI complete medium containing 10% FCS, 10 mM HEPES buffer, 2 mM L-glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin (Sigma, St. Louis, Mo.).
Livers from infected mice were harvested and homogenized for 30 s at low speed in a blender. The granulomas were collected by centrifugation at 500 g and washed twice in RPMI. The granulomas were dispersed by agitation in a shaking water bath at 37°C for 35 min in RPMI containing 5 mg/ml collagenase (type I from Clostridium histolyticum, Sigma). The granuloma cells then were dispersed further by repeated cycles of suction and expulsion through a 1 ml syringe, and the dispersed cells were passed through sterile gauze to filter out residual particulate matter. The granuloma cells then were washed twice in RPMI and resuspended in 20 ml of RPMI complete medium. Viability of all cells was always Ͼ95% as determined using eosin Y exclusion dye. The granuloma cells were composed of ϳ50% eosinophils, 30% macrophages, 10% CD4ϩ T cells, 2% CD8ϩ T cells, and 5% B cells.
Cell lines D 1.1 and D10.G 4.1, the Th1 and Th2 cell lines, were obtained from Dr. Abbas (Harvard University, Cambridge, Mass.) and the American Tissue Culture Collection (ATCC) (Rockville, Md.), respectively. The other T cell lines were established from the dispersed granuloma cells of normal CBA/J and C57BL/6 mice, and from IL-4 knockout mice as described (15) .
To establish the polyclonal T lymphocyte cell lines, 5 ϫ 10 7 dispersed granuloma cells were incubated for 10 -15 min at 37°C in nylon wool columns pretreated with RPMI. The column nonadherent cells were washed extensively and cultured in T25 flask in 10 ml RPMI containing 10% FCS and 10% supernatant from Con A-stimulated normal spleen cells. These cultures were washed and fed weekly with fresh conditioned medium. After 4 wk, the granuloma cell cultures demonstrated stable growth. At this point, the cultures were split and aliquots frozen in liquid nitrogen. These primary cell lines were composed of CD4ϩ T cells (Ͼ95%) and propagated in culture like normal long-term cell lines.
Induction/modulation of VPAC2 mRNA
Splenocytes or granuloma cells (5ϫ10 7 cells/flask) in 10 ml RPMI complete medium were incubated at 37°C in T25 flasks usually for 3 days. Some cultures also contained 0.1 mg anti-CD3 (2C11, Dr. Bluestone, University of Chicago, Chicago, Ill.) and/or anti-IL-4 mAb (0.1 mg/ml) (11B11, ATCC), rIL-4 (usually at 200 U/ml)(Biological Response Modifiers Program, National Institutes of Health, Bethesda, Md. or R&D Systems, Minneapolis, Minn.), or rat IgG isotype control (ZYMED, San Francisco, Calif.). Also, some cultures contained soluble egg antigen (SEA) at up to 5 g/ml. SEA was made as described previously (14) . After the incubation, RNA was extracted from the cells for RT-PCR analysis. Splenocyte and granuloma cell viability after the 3 day culture were ϳ70 and 50%, respectively. Anti-IL-4 or rIL-4 treatment did not appear to affect cell yield or viability.
T cell lines (15-20ϫ10 7 cells/flask) were cultured in T75 flasks for 72 h at 37°C in 20 ml of RPMI 1640 complete medium supplemented with 100 U/ml of rhIL-2. Some cultures contained rIL4, anti-IL-4, or isotype control mAb as describe above. After incubation, the cells were washed, RNA extracted, and RT-PCR performed.
T cell lysis
Added to 5 ϫ 10 7 cell suspensions was 50 -100 l of appropriate cytolytic anti-Thy 1.2 (Accurate Chemical and Scientific, Westberg, N.Y.), anti-CD4 (GK1.5), or anti-CD8 mAb (TIB211) (hybridoma cell lines from ATCC). After incubation on ice for 1 h, the cells were spun down, the supernatant was decanted, and LOW-TOX complement (Accurate Chemical and Scientific) was added at a 1:10 final dilution. The cells then were suspended gently and incubated at 37°C for 1 h more. This antibody and complement lysis was repeated one more cycle to assure thorough deletion of T cells or T cell subsets. Appropriate selective deletion was confirmed using flow cytometry.
Cytokine assays
Cytokines were quantified in supernatants using two sandwich ELISAs. IL-4 was captured with 11B11 and detected with biotinylated BVD6 (DNAX, Palo Alto, Calif.). The sensitivity of the IL-4 ELISA was 100 pg/ml. IL-5 was captured with TRFK5 and detected with biotinylated TRFK4 (DNAX). The sensitivity of the IL-5 ELISA was 30 pg/ml. IFN-␥ was captured with HB170 (ATCC) and detected with a rabbit polyclonal anti-IFN-␥ antiserum (Dr. Mary Wilson, University of Iowa, Iowa City, Iowa) followed by application of biotinylated goat anti-rabbit mAb (Accurate Chemical and Scientific). The sensitivity of the IFN-␥ ELISA was 30 pg/ml. All ELISAs used streptavidin-peroxidase conjugate and ABTS substrate (Zymed).
RNA extraction, RT-PCR, and competitive PCR assay for VPAC2
The total cellular RNA was extracted and RT-PCR performed as mentioned previously (1) . The spleen or granuloma cells (5ϫ10 7 ) were washed twice in RPMI, and the pelleted cells were homogenized in guanidinium/acid-phenol to extract the RNA. The RNA was quantified spectrophotometrically and checked for intact 18S and 28S bands by gel electrophoresis. RT reactions were incubated 2 h at 40°C in 40 l containing 400 units of M-MLV reverse transcriptase, 0.5 g of RNA, and 0.5 g 18-mer oligo (dT) for random priming. The first strand cDNA was diluted to 250 l, and 0.1 l of the product was used in each PCR reaction. PCR was performed in a total volume of 50 l using 3 units of Taq DNA polymerase and primers specific for VPAC2 as mentioned elsewhere (13) .
A quantitative RT-PCR assay was performed to measure the amount of VPAC2 mRNA in total cellular RNA preparations as described (13) . The concentration of the unknown mRNA was determined through competition with known concentration of an engineered plasmid, containing an appropriate VPAC2 cDNA fragment, in a PCR followed by localization of bands of equivalence. All RNA preparations were compared for 18S-and 28S-band expression to assure uniformity of extraction.
RESULTS
Anti-IL-4 mAb enhances VPAC2 mRNA expression in vitro
In murine S. mansoni, we previously reported that granuloma T cells constitutively express VPAC2 mRNA, whereas none is detected in splenocytes from these infected CBA mice (13) . This again was confirmed using a VPAC2 RT-PCR assay sensitive Ͻ0.1 fg VPAC2 mRNA/g total RNA. This suggested that T cell VPAC2 mRNA expression is inducible on T cell subsets.
To address this issue further, splenocytes from schistosome-infected CBA mice were incubated in vitro with anti-CD3 or various concentrations of SEA for up to 7 days, but neither stimulus induced VPAC2 mRNA expression as determined by RT-PCR. Spleen cells from these infected animals make large amounts of IL-4. It was discovered that VPAC2 mRNA appeared when splenocytes were cultured for as little as 3 days with anti-CD3 and neutralizing anti-IL-4 mAb (Fig. 1) . Control mAb had no effect suggesting that IL-4 was preventing VPAC2 expression in these cell cultures. Splenocytes cultured alone or with only anti-IL-4 mAb did not express VPAC2 mRNA (data not shown).
Next, it was determined if IL-4 also influenced the level of VPAC2 mRNA expression in granuloma cells. Dispersed granuloma cells constitutively expressed VPAC2 mRNA. This natural expression decreased substantially when cells were cultured in vitro for 3 days with or without anti-CD3 stimulation. However, granuloma cells cultured with both anti-CD3 and anti-IL-4 mAbs strongly expressed VPAC2 mRNA (Fig. 1) . Once more, control mAb had no effect.
Using a competitive RT-PCR assay developed in our laboratory (Fig. 2) , we measured the content of VPAC2 mRNA in the cell cultures. This assay showed that both splenocytes and granuloma cells incubated in vitro with blocking anti-IL-4 mAb expressed much larger amounts of VPAC2 mRNA than cells maintained without blocking Ab (Fig. 3) .
Using RT-PCR, VPAC2 mRNA also was sought in splenocytes from normal uninfected CBA mice. None was detected even when cells were maintained in vitro for up to 3 days with either neutralizing IL-4 mAb or rIL-4 (Fig. 4) . Thus, it appeared that the systemic effects of schistosome infection were required for the induction of splenic VPAC2 mRNA.
IL-4 KO mice strongly express VPAC2 mRNA, and this expression is down-regulated by rIL-4
To further explore the potential importance of IL-4 in limiting VPAC2 mRNA expression, experiments were performed using C57BL/6 IL-4 KO mice infected with S. mansoni. These mice form granulomas, in response to schistosome ova, which are nearly normal in size. However, the granulomas produce no IL-4, make little IL-5, contain few eosinophils, and lack other features of a Th2 response (16) . In contrast to the CBA mouse strain, freshly isolated splenocytes from C57BL/6 mice did constitutively express small amounts of VPAC2 mRNA. Figure 5 shows that both dispersed splenocytes and granuloma cells from IL-4 KO mice constitutively expressed VPAC2 mRNA much stronger than their C57BL/6 wild-type controls. The difference in expression within the granulomas was greater than 30-fold as determined by quantitative RT-PCR (Fig.  3) . Unlike granuloma cells from wild-type mice, granuloma cells from IL-4 mutant mice continued to strongly express VPAC2 mRNA when maintained in vitro for 3 days with anti-CD3. However, addition of rIL-4 to the cell cultures resulted in nearly a 20-fold diminution in VPAC2 mRNA expression (Fig. 6 and  Fig. 3 ).
IL-4 regulates VPAC2 mRNA expression in CD4؉ T cells
Previous experiments showed that granuloma T cells were the major source of VPAC2 mRNA within the schistosome granuloma of CBA mice. Because both CBA mouse splenocytes and granuloma cells maintained in vitro for 3 days with anti-CD3 and neutralizing anti-IL-4 mAb strongly expressed VPAC2 mRNA, it was determined if T cell deletion after the incubation affected the level of receptor mRNA detectable in these dispersed mixed-cell cultures. The granuloma cells were composed of ϳ50% eosinophils, 30% macrophages, 10% CD4ϩ T cells, 2% CD8ϩ T cells, and 5% B cells. The splenocytes contained ϳ70% B cells, 15% CD4ϩ T cells, and 8% CD8ϩ T cells. These experiments used cells from CBA mice.
After the 3 day incubation with anti-CD3 and anti-IL-4 mAbs, anti-Thy-1.2 and complement treatment was used to deplete the splenic and granuloma T cell subpopulation by Ͼ99% as determined by flow cytometry. RNA extracted from the cells depleted of Thy-1.2ϩ lymphocytes and reverse transcribed contained no detectable VPAC2 cDNA. However, PCR amplification of reversed transcribed RNA from cells treated with normal mouse serum and complement yielded VPAC2 cDNA product (Fig. 7) .
To further localize VPAC2 mRNA expression after the 3 day incubation, cells also were depleted of CD4ϩ or CD8ϩ T cell subsets using appropriated cytolytic mAbs and complement. Figure 8 and Table  1 show that RT-PCR could detect little or no VPAC2 cDNA in reverse transcribed mRNA extracted from CD4-deleted splenocytes. Yet, cells treated with NMS or anti-CD8 yielded the expected amounts of VPAC2 cDNA product. Similar experiments using granuloma cells provided equivalent results. These studies suggested that CD4ϩ T cells were the source of VPAC2 mRNA in the granuloma and spleen cell cultures, and that VPAC2 mRNA expression within these cells was subject to IL-4 regulation.
IL-4 regulates VPAC2 mRNA levels in CD4؉ Th2, but not Th1 cell lines
Three CD4ϩTh2 cell lines were used to further explore the role of IL-4 in modulating VPAC2 mRNA expression. These included the D10 Th2 cell line and the C57BL/6 and CBA/J Th2 cell lines produced in our laboratory from schistosome granulomas. All make large amounts of IL-4 and IL-5, and little or no IFN-␥ (data not shown). Reverse transcribed mRNA from each line contained small amounts of VPAC2 cDNA as determined by RT-PCR. Neutralizing anti-IL-4 mAb added to cell cultures for 3 days substantially enhanced this expression (Fig. 9) . Although the anti-IL-4 mAb did block IL-4 activity, it did not significantly alter IL-5 or IFN-␥ release over the 3 day incubation.
We also examined the effect of rIL-4 on VPAC2 mRNA expression in CD4ϩ Th1 cell lines. These included the well-characterized cell line D1.1 and a Th1 cell line derived from the granuloma of the IL-4 KO mouse. Relative to Th2 cell lines, RT-PCR amplification detected larger amounts of VPAC2 mRNA in Th1 cell lines. This high level of expression did not decrease when the Th1 cells were exposed to even large amounts of rIL-4 for up to 3 days in vitro (Fig. 9) . All cell lines were studied in the absence of feeder cells.
DISCUSSION
In this study, it was determined if we could induce T cells to express VPAC2 mRNA and whether inflammatory mediators would regulate the level of this expression. It previously was shown that Thy 1.2ϩ 
a Spleen cells from mice infected with schistosomiasis were cultured in vitro for 72 h with anti-CD3 and anti-IL-4 mAbs as described in Fig. 1 . Cells were depleted of either CD4ϩ or CD8ϩ lymphocytes after the 3 day culture period using anti-CD4 or anti-CD8 mAb and complement lysis (anti-CD4 or anti-CD8 ϩ C). Control cells were treated with normal mouse serum and complement (NMS ϩ C). After cell deletion, RNA was extracted from the remaining cells and reverse transcribed. VPAC2 mRNA was measured using quantitative PCR. Data are mean fg VPAC2 cDNA/0.4 g total cellular RNA Ϯ sd from each of two separate experiments. BD, below detection.
granuloma T cells in murine schistosomiasis contained VPAC2 mRNA, which was not evident in the resting splenocytes of normal or infected mice (13) . Because dispersed splenocytes are composed of ϳ25% T lymphocytes, it was assumed that VPAC2 mRNA would be readily inducible in splenic T cell subsets. However, we did not incite VPAC2 expression in splenocytes from schistosome-infected mice even after 1 wk of TCR stimulation with SEA or anti-CD3. This suggested that splenocytes from these schistosome-infected animals contained no cells capable of VPAC2 mRNA expression or that some factor was preventing expression.
Schistosomiasis is a parasitic disease in which ova induce a strong systemic Th2 response associated with the production of large quantities of IL-4 and IL-5. IL-4 is critically important for expression of the Th2 phenotype in murine schistosomiasis (16) . Thus, we determined if IL-4 was an important factor in controlling VPAC2 mRNA expression.
We found that cells stimulated through their TCR in the presence of neutralizing anti-IL-4 mAb strongly expressed VPAC2 mRNA. To further address the importance of IL-4 in VPAC2 regulation, we showed that both the granuloma cells and splenocytes of IL-4 KO mice naturally expressed VPAC2 mRNA stronger than cells from the wild-type controls and that rIL-4 significantly inhibited this expression. The composite of these experiments firmly support the hypothesis that IL-4 is a strong down-modulator of both VPAC2 mRNA induction and ongoing expression in T cells of schistosome-infected animals.
Splenocytes of normal uninfected CBA mice did not express VPAC2 mRNA even after TCR activation. These cells released no detectable IL-4 and failed to express VPAC2 mRNA even when cultured with IL-4 neutralizing mAb. In some experiments, splenocytes were maintained in culture for several weeks without evidence of VPAC2 expression (data not shown). Thus, it appears that the process of infection in murine schistosomiasis played an important role in priming VPAC2 mRNA expression in splenocytes of at least the CBA mouse strain.
Schistosome-infected mice have enlarged spleens that contain CD4ϩ T cells, CD8ϩ T cells, and B cells in normal proportions. Yet, a small fraction of the T cells are activated and secrete IL-4 and IL-5, which is most evident after soluble schistosome egg antigen or anti-CD3 mAb stimulation. There are non-T cell elements making IL-4 also (17) . The presence of these lymphokines alters the phenotypes of the accompanying resting B cells shown by elevated CD32, class II MHC, and IL-2R expression (18) . Although schistosome infection modulates splenocyte activation and differentiation in many ways, the precise factors that prime splenic T cells for VPAC2 mRNA expression remain unknown.
In this study, we also showed that VPAC2 mRNA localized mostly, if not exclusively, to splenocyte and granuloma CD4ϩ T cells from schistosome-infected mice. This suggested that VPAC2 was subject to induction and regulation in the splenic and granuloma CD4ϩ T lymphocytes. Because the appearance of VPAC2 mRNA in splenocytes required 3 days of stimulation in vitro, it is possible that this receptor is a marker of chronically activated primary effector or memory T cells. Granuloma CD4ϩ T cells, which contain VPAC2 mRNA, all display the phenotype of activated T cells (CD44 high, L-selectin low) (19) , further supporting this contention.
There are several cell surface markers that can help distinguish Th1 from Th2 cells. For instance, human and murine Th2 cells, as opposed to Th1, at least transiently express CD30 (20) and the eotaxin receptor CCR3 (21) . They also constitutively and stably express a receptor-like molecule of uncertain function called ST2L (22) . Th1 cells, in contrast to Th2, display the IL-12R beta2 subunit prominently (23) . As presented here, a series of Th1 and Th2 murine cell lines showed that Th1 cells, as opposed to Th2 lymphocytes, were strong stable producers of VPAC2 mRNA. Thus, high level expression of VPAC2 mRNA may be an additional marker of the Th1 cell subset. However, Th2 cells can express VPAC2 mRNA in large amounts if the cells are cultured with blocking anti-IL-4 mAb. Hence, IL-4 governs the amount of VPAC2 mRNA in Th2 cells.
It was noteworthy that Th1 cell lines contained large amounts of VPAC2 mRNA, but that rIL-4 failed to down-modulate this expression. While murine Th1 cells express IL-4R in comparable numbers to those of Th2 cells, they have a major defect in IL-4R signaling through the Stat 6 pathway (24) . It is tempting to speculate that the failure of rIL-4 to inhibit VPAC2 mRNA production in our Th1 cell lines was secondary to this defective IL-4R signaling.
There are two distinct VIP receptors called VPAC1 and VPAC2 (12) . The receptors share only ϳ50% homology in amino acid sequence and display differences in intracytoplasmic tails. Both are G protein-coupled receptors that activate adenylate cyclase. VPAC1 mRNA is expressed widely throughout the immune system of normal healthy mice. In schistosomiasis, VPAC1 mRNA is in T cells and other immune cell types of both the granulomas and spleens. As shown above, the expression of VPAC2 mRNA is far more restricted than that of VPAC1. Experiments in vitro suggest that VIP can modulate lymphocyte proliferation as well as IL-2 and IL-5 production in schistosomiasis (11, 25) . Although the level of VPAC2 mRNA may help distinguish Th1 from Th2 cells, it remains uncertain if this receptor preferentially regulates Th1 cell function in murine schistosomiasis. Studies show that VIP can modulate cytokine production by murine lymphocytes and macrophages (5, 26) . Also, VIP may stimulate human T cell chemotaxis (27) and inhibit human monocyte TNF and IL-12 production (28) via VPAC2.
